BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

533 related articles for article (PubMed ID: 7499831)

  • 1. Alloantigen-induced human lymphocytes rendered nonresponsive by a combination of anti-CD80 monoclonal antibodies and cyclosporin-A suppress mixed lymphocyte reaction in vitro.
    Comoli P; Montagna D; Moretta A; Zecca M; Locatelli F; Maccario R
    J Immunol; 1995 Dec; 155(12):5506-11. PubMed ID: 7499831
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential regulatory signals delivered by antibody binding to the CD28 (Tp44) molecule during the activation of human T lymphocytes.
    Damle NK; Doyle LV; Grosmaire LS; Ledbetter JA
    J Immunol; 1988 Mar; 140(6):1753-61. PubMed ID: 2964482
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antigen presentation by epithelial cells induces anergic immunoregulatory CD45RO+ T cells and deletion of CD45RA+ T cells.
    Marelli-Berg FM; Weetman A; Frasca L; Deacock SJ; Imami N; Lombardi G; Lechler RI
    J Immunol; 1997 Dec; 159(12):5853-61. PubMed ID: 9550381
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anergic cells induced by the blockade of CD40-CD154 and CD28-B7 costimulatory pathways act as potent immunoregulatory cells in vitro and vivo.
    Cai Y; Zhou PJ; Tang XD
    Chin Med J (Engl); 2004 Aug; 117(8):1178-83. PubMed ID: 15361291
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Induction of tolerance by IL-10-treated dendritic cells.
    Steinbrink K; Wölfl M; Jonuleit H; Knop J; Enk AH
    J Immunol; 1997 Nov; 159(10):4772-80. PubMed ID: 9366401
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumor promoters in conjunction with calcium ionophores mimic antigenic stimulation by reactivation of alloantigen-primed murine T lymphocytes.
    Isakov N; Altman A
    J Immunol; 1985 Dec; 135(6):3674-80. PubMed ID: 2999231
    [TBL] [Abstract][Full Text] [Related]  

  • 7. T cell responses to allogeneic human mesenchymal stem cells: immunogenicity, tolerance, and suppression.
    Klyushnenkova E; Mosca JD; Zernetkina V; Majumdar MK; Beggs KJ; Simonetti DW; Deans RJ; McIntosh KR
    J Biomed Sci; 2005; 12(1):47-57. PubMed ID: 15864738
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Induction of alloantigen-specific T cell tolerance through the treatment of human T lymphocytes with wortmannin.
    Taub DD; Murphy WJ; Asai O; Fenton RG; Peltz G; Key ML; Turcovski-Corrales S; Longo DL
    J Immunol; 1997 Mar; 158(6):2745-55. PubMed ID: 9058809
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lack of CD80 expression by fibroblast-like synoviocytes leading to anergy in T lymphocytes.
    Corrigall VM; Solau-Gervais E; Panayi GS
    Arthritis Rheum; 2000 Jul; 43(7):1606-15. PubMed ID: 10902766
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Peptide-induced anergy in allergen-specific human Th2 cells results in lack of cytokine production and B cell help for IgE synthesis. Reversal by IL-2, not by IL-4 or IL-13.
    Fasler S; Aversa G; Terr A; Thestrup-Pedersen K; de Vries JE; Yssel H
    J Immunol; 1995 Nov; 155(9):4199-206. PubMed ID: 7594575
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The combination of anti-B7 monoclonal antibody and cyclosporin A induces alloantigen-specific anergy during a primary mixed lymphocyte reaction.
    Van Gool SW; de Boer M; Ceuppens JL
    J Exp Med; 1994 Feb; 179(2):715-20. PubMed ID: 7507511
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Co-stimulation with 4-1BB ligand allows extended T-cell proliferation, synergizes with CD80/CD86 and can reactivate anergic T cells.
    Habib-Agahi M; Phan TT; Searle PF
    Int Immunol; 2007 Dec; 19(12):1383-94. PubMed ID: 17977894
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of precytotoxic T cells in cyclosporine-suppressed mixed lymphocyte reactions.
    Hooton JW; Miller CL; Helgason CD; Bleackley RC; Gillis S; Paetkau V
    J Immunol; 1990 Feb; 144(3):816-23. PubMed ID: 2136900
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Blocking CD40 - CD154 and CD80/CD86 - CD28 interactions during primary allogeneic stimulation results in T cell anergy and high IL-10 production.
    Van Gool SW; Vermeiren J; Rafiq K; Lorr K; de Boer M; Ceuppens JL
    Eur J Immunol; 1999 Aug; 29(8):2367-75. PubMed ID: 10458748
    [TBL] [Abstract][Full Text] [Related]  

  • 15. B7-blocking agents, alone or in combination with cyclosporin A, induce antigen-specific anergy of human memory T cells.
    Yi-qun Z; Lorré K; de Boer M; Ceuppens JL
    J Immunol; 1997 May; 158(10):4734-40. PubMed ID: 9144487
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interleukin-2, but not interleukin-15, is required to terminate experimentally induced clonal T-cell anergy.
    Bendiksen S; Rekvig OP
    Scand J Immunol; 2004; 60(1-2):64-73. PubMed ID: 15238074
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunoregulatory T cell circuits in man. Identification of a distinct T cell subpopulation of the helper/inducer lineage that amplifies the development of alloantigen-specific suppressor T cells.
    Damle NK; Mohagheghpour N; Kansas GS; Fishwild DM; Engleman EG
    J Immunol; 1985 Jan; 134(1):235-43. PubMed ID: 3155461
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Specific hyporesponsiveness of alloreactive peripheral T cells induced by CD4 antibodies.
    Vincent C; Fournel S; Wijdenes J; Revillard JP
    Eur J Immunol; 1995 Mar; 25(3):816-22. PubMed ID: 7705413
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interaction of human mesenchymal stem cells with cells involved in alloantigen-specific immune response favors the differentiation of CD4+ T-cell subsets expressing a regulatory/suppressive phenotype.
    Maccario R; Podestà M; Moretta A; Cometa A; Comoli P; Montagna D; Daudt L; Ibatici A; Piaggio G; Pozzi S; Frassoni F; Locatelli F
    Haematologica; 2005 Apr; 90(4):516-25. PubMed ID: 15820948
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tac antigen-positive T cells activated in autologous mixed lymphocyte reaction regulate the generation of killer T cells against hapten-modified autologous cells.
    Kumagai S; Namiuchi S; Ozaki S; Sano H; Tsubata T; Suginoshita T; Imura H
    J Immunol; 1985 Feb; 134(2):711-7. PubMed ID: 2981269
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.